CB

Calithera Biosciences

CALA
OTCHealth Care
$0.00
USD
+0.00(0.00%)
At close: Jun 12, 20:00 UTC

Open

Prev. Close

High

Low

Market Snapshot

Market Cap

$1.46K

P/E Ratio

-0.0

EPS

-5.80

Employees

8

About

Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. The firm is winding up its operations. The firm is seeking to sell all of its clinical assets and programs. The firm has not generated any revenue.